| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 0.39 F1 (all fusions, conventional RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'F1' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 1,039 False negatives (all fusions, conventional RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'False negative' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 1,061 False positives (all fusions, conventional RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'False positive' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 0.39 Precision (all fusions, conventional RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'Positive predictive value' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 0.39 Recall (all fusions, conventional RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive rate' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 678 True positives (all fusions, conventional RNA-seq of cell lines) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 0.47 F1 (all fusions, targeted RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'F1' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 117 False negatives (all fusions, targeted RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'False negative' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 76 False positives (all fusions, targeted RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'False positive' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 0.53 Precision (all fusions, targeted RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'Positive predictive value' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 0.43 Recall (all fusions, targeted RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive rate' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 87 True positives (all fusions, targeted RNA-seq of cell lines) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 0.97 F1 (driver fusions, conventional RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'F1' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 4 False negatives (driver fusions, conventional RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'False negative' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 0 False positives (driver fusions, conventional RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'False positive' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 1 Precision (driver fusions, conventional RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'Positive predictive value' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 0.93 Recall (driver fusions, conventional RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive rate' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 57 True positives (driver fusions, conventional RNA-seq of cell lines) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 0.96 F1 (driver fusions, targeted RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'F1' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 2 False negatives (driver fusions, targeted RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'False negative' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 0 False positives (driver fusions, targeted RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'False positive' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 1 Precision (driver fusions, targeted RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'Positive predictive value' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 0.92 Recall (driver fusions, targeted RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive rate' (PDF page text) |
|---|
| Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026) | Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 22 True positives (driver fusions, targeted RNA-seq of cell lines) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive' (PDF page text) |
|---|